I-Cidofovir Anhydrous 113852-37-2 I-Antiviral
Inkokhelo:T/T, L/C
Umsuka Womkhiqizo:China
Imbobo yokuthutha:Beijing/Shanghai/Hangzhou
Amandla okukhiqiza:1kg/ngenyanga
I-oda(MOQ):1g
Isikhathi esiholayo:3 Izinsuku Zokusebenza
Isimo sesitoreji:Igcinwe endaweni epholile neyomile, ivalwe futhi igweme ukukhanya.
Impahla yephakheji:ibhodlela, ibhodlela
Usayizi wephakheji:1g/ibhodlela, 5/ibhodlela, 10g/ibhodlela, 50g/ibhodlela, 500g/ibhodlela
Ulwazi lokuphepha:UN 2811 6.1/ PG 3
Isingeniso
I-Cidofovir dihydrate i-dihydrate yohlobo lwe-cidofovir olunganamanzi.I-nucleoside analogue, iyi-antiviral ejovwayo esetshenziselwa ukwelapha i-cytomegalovirus (CMV) retinitis ezigulini ezine-AIDS.Inendima njengesidakamizwa esilwa namagciwane kanye ne-antineoplastic agent.
Ukucaciswa (izinga lasendlini)
| Izinto | Imininingwane |
| Ukubukeka | Impushana emhlophe ukuya emhlophe |
| Ukuhlonza
| I-Infrared Spectroscopy |
| Isikhathi sokugcinwa kwesixazululo Sesampuli sihambisana naleso Sesixazululo Esijwayelekile, njengoba sitholwe ku-Assay. | |
| Izinsalela ekushiseni | ≤0.5% |
| Ukungcola Okuphilayo
| I-analogue ye-Cidofovir diola≤0.15% |
| Inhlanganisela ehlobene ne-Cidofovir A ≤0.15% | |
| Inhlanganisela ehlobene ne-Cidofovir B ≤0.15% | |
| I-analogue ye-Cidofovir uracilb ≤0.15% | |
| I-Bromocidofovirc≤0.15% | |
| Noma ikuphi ukungcola komuntu okungacacisiwe ≤0.10% | |
| Ukungcola okuphelele ≤1.0% | |
| I-Enantiomeric Purity | ≤1.0% |
| Ukuhlolwa Kwezibalo Ze-Microbialkanye Nokuhlola Amagciwane Acacisiwe | Isamba sesibalo sebhaktheriya ye-aerobic yi-NMT 102cfu/g.Isamba sesikhunta esihlanganisiwe nesibalo se-yeast yi-NMT 101cfu/g. |
| Ukunqunywa kwamanzi | ≤0.5% |
| pH | 2.5-4.5 |
| Isivivinyo | 98.0% -102.0%, ngesisekelo se-anhydrous |
